In the extensively studied TH-MYCN murine model of NB in which MYCN is expressed under control of the tyrosine hydroxylase promoter, we administered CYC065 either orally or by intraperitoneal injection (Figure 6C and Supplemental Figure 8, B and C). The gene discussed is MYCN; the disease is neuroblastoma.